With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
Our Corporate and Business Development team is responsible for evaluating and driving the execution of strategic growth opportunities for BenevolentAI via partnerships and collaborations, execution of licensing deals, and robust opportunity and portfolio analysis ensuring the appropriate rigour of commercial thinking is applied throughout our pipeline to underpin future growth.
As a member of the Business Development team, you will help drive future growth for Benevolent leading Commercial, Portfolio, and Licensing projects
You will be joining a growing team reporting to VP Business Development and working closely with others across the business. The role requires engaging various internal and external stakeholders, working closely with the Executive Team and collaborating across teams and functions. It also involves communicating and presenting the business opportunities internally to key stakeholders and externally to potential partners.
This is an important role that offers the opportunity to help shape the company’s growth trajectory and business opportunities and make a transformative impact in the drug discovery industry.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. BenevolentAI has a consistently proven track record of scientifically validated discoveries. The BenevolentAI Platform™ powers a growing in-house pipeline of over 20 disease programmes, spanning from target discovery to clinical studies, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email email@example.com. Thank you.